[1] 韩济生.神经科学[M].3版.北京:北京大学医学出版社,2009,131.
[2] Stephen C Heinrichs, Kimberly A Leite-Morris, Marsha D Guy. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice[J]. Behav Brain Res, 2013, 248: 80-84.
[3] Laurie L Wellman ,Yang Ling-hui, Marta A Ambrozewicz. Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of corticotropin-releasing factor[J]. Sleep, 2013, 36(4): 471-480.
[4] Ayako M Watabe, Toshitaka Ochiai, Masashi Nagase. Synaptic potentiation in the nociceptive amygdala following fear learning in mice[J]. Mol Brain, 2013, 6(11): 1-14.
[5] Donzis E J, Rennaker R L, Thompson L T. Fear conditioning alters neuron-specific hippocampal place field stability via the basolateral amygdale[J]. Brain Res, 2013, 1525: 16-25.
[6] Yang Zhen-dong, Zhou Xiang-yu, Zhang Qi. Effectiveness and safety of memantine treatment for Alzheimer's disease[J]. J Alzheimers Dis, 2013, 36(3):445-458.
[7] Claudio Babiloni, Claudio Del Percio, Regis Bordet, et al. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients[J]. Clin Neurophysiol, 2013, 124(5): 837-850.
[8] Gabriele Sani, Giulia Serra, Giorgio D Kotzalidis, et al. The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence[J]. CNS Drugs, 2012, 26(8): 663-690.
[9] Matthew A Battista, Robert Hierholzer, Hani Raoul Khouzam, et al. Pilot trial of memantine in the treatment of posttraumatic stress disorder[J]. Psychiatry, 2007, 70(2): 167-174.
[10] Jung Goo Lee, Sae Woom Lee, Bong Ju Lee, et al. Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study[J]. Psychiatry Investig, 2012, 9(2): 166-173.
[11] Jorge Camarasa, José M Marimón, Teresa Rodrigo, et al. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats[J]. Eur J Pharmacol, 2008, 589(1-3): 132–139.
[12] Jorge Camarasa, Teresa Rodrigo, David Pubill, et al. Memantine is a useful drug to prevent the spatial and non-spatial memory de?cits induced by methamphetamine in rats[J]. Pharmacol Res, 2010, 62(5): 450–456.
[13] Alberto C S Costa, Jonah J Scott-McKean, Melissa R Stasko. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test[J]. Neuropsychopharmacology, 2008, 33(7): 1624-1632.
[14] Bechara J Saab, Ruxandra M Luca, Wing B Yuen, et al. Memantine affects cognitive flexibility in the morris water maze[J]. J Alzheimer’s Dis, 2011, 27(3): 477–482.
[15] Dong Hong-xin, Carla M Yuede, Carolyn Coughlan, et al. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease[J]. Neuropsychopharmacology, 2008, 33(13): 3226-3236.
[16] Johannes Kornhuber, Evelin M Kennepohl, Stefan Bleich, et al. Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach[J]. Clin Pharmacokinet, 2007, 46(7): 599-612.
|
